RecruitingPhase 4NCT06848946
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intracameral Implant) in Conjunction With Cataract Surgery vs. Cataract Surgery Alone
Sponsor
Glaukos Corporation
Enrollment
132 participants
Start Date
Jan 13, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
Eligibility
Min Age: 45 Years
Inclusion Criteria2
- Cataract diagnosis: clinically significant age-related cataract eligible for phacoemulsification in the study eye.
- OAG or OHT diagnosis: either OAG (i.e. primary, pseudoexfoliation, or pigmentary glaucoma) or OHT in the study eye (i.e., eye to undergo cataract surgery)
Exclusion Criteria2
- Active corneal inflammation or edema.
- Retinal disorders not associated with glaucoma.
Interventions
COMBINATION_PRODUCTiDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery
iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery
PROCEDURESham procedure in conjunction with cataract surgery
Sham procedure in conjunction with cataract surgery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06848946
Related Trials
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
NCT060666451 location
Feasibility Clinical Evaluation of the Calibreye System
NCT058850224 locations
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
NCT066852111 location
Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NCT056259586 locations
SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients
NCT071521321 location